📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infections. (2021)

First Author: Dupont L

Attributed to: Using iPSC variation to define HIV-1 regulatory networks funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.06.07.21258351

PubMed Identifier: 34127977

Publication URI: http://europepmc.org/abstract/MED/34127977

Type: Journal Article/Review

Parent Publication: medRxiv : the preprint server for health sciences